Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine R Swanson

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|November 20, 2015
Reply to letter: Plasma fasting cholesterol profiles and age at onset in Parkinson's diseaseChristine R Swanson, Roy N Alcalay, Alice Chen-Plotkin
Frontiers in Bioscience (Landmark Edition)|March 11, 2009
Can we prevent parkinson's disease?Christine R Swanson, Samantha L Sesso, Marina E Emborg
PPAR Research|November 14, 2013
Neuroprotective Properties of a Novel Non-Thiazoledinedione Partial PPAR- γ Agonist against MPTPChristine R Swanson, Eric Du, Delinda A Johnson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 25, 2015
Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson's disease patientsChristine R Swanson, Yosef Berlyand, Sharon X Xie, et al.
Journal of Neuroinflammation|August 9, 2011
The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeysChristine R Swanson, Valerie Joers, Viktoriya Bondarenko, et al.
Plos One|June 30, 2012
A monoclonal antibody-GDNF fusion protein is not neuroprotective and is associated with proliferative pancreatic lesions in parkinsonian monkeysSachiko Ohshima-Hosoyama, Heather A Simmons, Nichole Goecks, et al.
Stereotactic and Functional Neurosurgery|June 20, 2014
Titer and product affect the distribution of gene expression after intraputaminal convection-enhanced deliveryMarina E Emborg, Samuel A Hurley, Valerie Joers, et al.
Annals of Clinical and Translational Neurology|May 28, 2016
Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's diseaseNicholas S Lim, Christine R Swanson, Hua-Ren Cherng, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 18, 2014
Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotypeChristine R Swanson, Katherine Li, Travis L Unger, et al.
Plos Medicine|October 12, 2019
Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysisMarijan Posavi, Maria Diaz-Ortiz, Benjamine Liu, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Movement Disorders : Official Journal of the Movement Disorder Society|November 20, 2015
Reply to letter: Plasma fasting cholesterol profiles and age at onset in Parkinson's diseaseChristine R Swanson, Roy N Alcalay, Alice Chen-Plotkin
Frontiers in Bioscience (Landmark Edition)|March 11, 2009
Can we prevent parkinson's disease?Christine R Swanson, Samantha L Sesso, Marina E Emborg
PPAR Research|November 14, 2013
Neuroprotective Properties of a Novel Non-Thiazoledinedione Partial PPAR- γ Agonist against MPTPChristine R Swanson, Eric Du, Delinda A Johnson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 25, 2015
Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson's disease patientsChristine R Swanson, Yosef Berlyand, Sharon X Xie, et al.
Journal of Neuroinflammation|August 9, 2011
The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeysChristine R Swanson, Valerie Joers, Viktoriya Bondarenko, et al.
Plos One|June 30, 2012
A monoclonal antibody-GDNF fusion protein is not neuroprotective and is associated with proliferative pancreatic lesions in parkinsonian monkeysSachiko Ohshima-Hosoyama, Heather A Simmons, Nichole Goecks, et al.
Stereotactic and Functional Neurosurgery|June 20, 2014
Titer and product affect the distribution of gene expression after intraputaminal convection-enhanced deliveryMarina E Emborg, Samuel A Hurley, Valerie Joers, et al.
Annals of Clinical and Translational Neurology|May 28, 2016
Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's diseaseNicholas S Lim, Christine R Swanson, Hua-Ren Cherng, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 18, 2014
Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotypeChristine R Swanson, Katherine Li, Travis L Unger, et al.
Plos Medicine|October 12, 2019
Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysisMarijan Posavi, Maria Diaz-Ortiz, Benjamine Liu, et al.
Pageof 1